Becton Dickinson and Co (NYSE:BDX)
| 262.62 Delayed Data As of Jan 14 |  -1.07 / -0.41%Today’s Change | 235.13 Today|||52-Week Range 265.23 | +4.43% Year-to-Date |
Latest BDX News | Press Releases
| Why the Earnings Surprise Streak Could Continue for Becton Dickinson (BDX) Jan 14 / Zacks.com - Paid Partner Content | BD (BDX) Product Gets FDA Nod, Patient Outcome to Get a Boost Jan 10 / Zacks.com - Paid Partner Content |
| Here's Why You Should Retain BD (BDX) Stock in Your Portfolio Jan 11 / Zacks.com - Paid Partner Content | 4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy Jan 06 / Zacks.com - Paid Partner Content |
| 5 Best Stocks to Buy in January and Hold Forever Jan 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 263.69 |
| Today’s open | 261.96 |
| Day’s range | 260.80 - 263.70 |
| Volume | 1,502,340 |
| Average volume (3 months) | 1,379,315 |
| Market cap | $74.9B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | +151.71% |
| Earnings growth (this year) | -4.92% |
| Earnings growth (next 5 years) | +3.50% |
| Revenue growth (last year) | +18.29% |
| P/E ratio | 38.3 |
| Price/Sales | 3.55 |
| Price/Book | 3.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | +0.29 | +0.65% |
| DXCMDexcom Inc | -8.62 | -1.89% |
| BAXBaxter International... | -0.15 | -0.17% |
| WSTWest Pharmaceutical ... | -1.12 | -0.29% |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $2.85 |
| Annual revenue (last year) | $20.2B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 10.33% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
